Drug Shortage Report for MYLAN-SUMATRIPTAN

Last updated on 2018-05-03 History
Report ID 28044
Drug Identification Number 02268922
Brand name MYLAN-SUMATRIPTAN
Common or Proper name SUMATRIPTAN
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6BL
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-05-14
Actual start date
Estimated end date Unknown
Actual end date 2018-05-02
Shortage status Avoided shortage
Updated date 2018-05-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v59 2018-05-03 French Compare
v58 2018-05-03 English Compare
v57 2018-05-02 French Compare
v56 2018-05-02 English Compare
v55 2018-05-01 French Compare
v54 2018-05-01 English Compare
v53 2018-04-23 French Compare
v52 2018-04-23 English Compare
v51 2018-04-16 French Compare
v50 2018-04-16 English Compare
v49 2018-04-13 French Compare
v48 2018-04-13 English Compare
v47 2018-03-19 French Compare
v46 2018-03-19 English Compare
v45 2018-03-08 English Compare
v44 2018-03-07 French Compare
v43 2018-03-07 English Compare
v42 2018-03-06 English Compare
v41 2018-03-02 French Compare
v40 2018-03-02 English Compare

Showing 1 to 20 of 59